NHINATIONAL HEALTH INVESTORS INC(NHI)Stock Analysis

AI analysis on 2,800+ stocks →
Real EstateNYSE
Institutional-grade research for retail investors
SEC EDGAR: CIK 877860NHI stock profile & AI dashboard →

13F Pro Quality Score

68.3/100

Rank #419 of 2,879 stocksTOP 25%

View Real Estate peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

76.8/100

Profitability

97.4/100

Balance Sheet

69.0/100

Earnings Quality

37.5/100

Free Cash Flow

97.8/100

Institutional Flow

44.6/100

Revenue Scale

13.2/100

Dilution Risk

47.3/100

NHI Stock Analysis & AI Quality Score

AI stock analysis and institutional research for NATIONAL HEALTH INVESTORS INC (NHI), a Real Estate sector company. 13F Pro's AI-powered ranking engine scores NHI at 68.3/100 on a 32-signal composite quality model, placing it at rank #419 of 2,879 stocks — the top 25% of the AI-ranked universe. NHI scores in the top quartile across free cash flow (97.8), profitability (97.4), revenue growth (76.8). Areas of concern include revenue scale (13.2) and earnings quality (37.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 47.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q4 2025), NATIONAL HEALTH INVESTORS INC reports quarterly revenue of $105.8M, net income of $38.2M, an operating margin of 36.1%. Top institutional holders of NHI by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. NHI trades on the NYSE exchange and files with the SEC under CIK 877860. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NHI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NATIONAL HEALTH INVESTORS INC directly from SEC EDGAR. NATIONAL HEALTH INVESTORS INC's 13F Pro composite quality score has ranged between 48 and 77 since 2021, currently 68.3 — a stable long-term trajectory across 28 quarterly and live scoring snapshots.

Fun facts about NATIONAL HEALTH INVESTORS INC

Quirks, history, and lore behind NHI — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    A U.S. real estate investment trust · mid-cap · listed on the NYSE · headquartered in Tennessee.
  • 2
    The Numbers
    Its portfolio spans roughly 150–200 properties across the country, and it has paid uninterrupted dividends to shareholders for decades — the REIT way of life.
  • 3
    The History
    Founded in the late 1980s, it was built around a simple thesis: America's population is aging, and somebody has to own the real estate where seniors live and heal.
  • 4
    The Secret
    It doesn't run hospitals or nursing homes — it just owns and leases them, collecting rent from operators and letting someone else deal with the bedpans.
  • 5
    The Lore
    Its tenants include senior housing communities, skilled nursing facilities, and medical office buildings — essentially a landlord for the grey-haired economy.
  • 6
    The Giveaway
    The ticker is three letters that stand for exactly what it does: National Health Investors, a Tennessee-based healthcare REIT betting on every baby boomer who ever existed.
▶ Think you know your stocks? Play the Daily Ticker

What's Driving NHI's Business? Latest 10-Q Breakdown

AI-extracted from NATIONAL HEALTH INVESTORS INC's 10-Q filed 2026-05-04 — Q1 2026 (quarter ended March 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

NHI reported Q1 2026 net income of $39.8M (+17.6% YoY) on total revenues of $115.1M (+28.9% YoY), driven by SHOP segment acquisitions and resident fee growth, while executing $560M sale of NHC portfolio.

Biggest Revenue Drivers

Total revenue: $115.1M+28.9% YoY

Rental income$73.2M+6.2% YoY

Real estate properties acquired since January 1, 2025 added $4.7M; fixed escalators and variable escalators contributed to growth.

Interest and other income$4.9M-23.8% YoY

Net reduction in principal amounts of mortgage and other notes receivable outstanding in current period.

Largest Expense Items

Depreciation and amortization$23.7M+23.7% YoY

Increased due to acquisitions completed since January 1, 2025; includes in-place lease intangible asset amortization.

Interest expense$15.0M+4.9% YoY

2033 Senior Notes issued September 2025 contributed; partially offset by lower borrowings on revolving credit facility.

General and administrative expenses$7.9M+15.0% YoY

Higher compensation costs compared to prior year period.

Watch Items from the Filing

  • NHC leased portfolio sale for $560M pending Hart-Scott-Rodino approval, anticipated July 2026 close; represents $13.8M net carrying amount but 10.3% of Q1 2026 revenues (11.9M); successful completion critical for capital redeployment strategy.
  • Bickford Senior Living represents 9.4% of revenues ($10.9M) and 38 properties; classified as cash-basis tenant since 2022 due to going-concern uncertainty; April 2026 lease amendments increased base rent to $38.4M annually with 2.0-3.0% escalators and contingent rent provisions.
  • Senior Living Communities LLC represents 12.4% of revenues ($14.3M) with 11 leased SHOs; straight-line rent negative adjustments of $0.4M in Q1 2026 indicate collectability concerns; occupancy trending lower at 86.6% vs. 84.9% sequentially.
  • SHOP segment occupancy at 86.6% (Q1 2026) versus 86.9% (Q4 2025); operating portfolio expanded to 35 communities with 3,469 units; leverage via acquisitions of 13 properties (799 units) and 7 transitioned properties (938 units) since January 1, 2025.
  • Mortgage and other notes receivable net of $15.3M credit loss reserves; two non-performing loans fully reserved ($12.0M unsecured SLM mezzanine, $1.2M unsecured Bickford); weighted 20% increase in probability of default and 20% loss increase applied to all other loans as of March 31, 2026.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Revenue

Q4 2025

$105.8M

Net Income

Q4 2025

$38.2M

Free Cash Flow

Q4 2025

$67.7M

Operating Margin

Q4 2025

36.1%

ROIC

Q4 2025

1.4%

D/E Ratio

Q4 2025

0.76

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+12.1% YoY
$375.6MFY 2025
FY21 $298.7MFY23 $319.8MFY24 $335.2MFY25 $375.6M

Net Income

+3.0% YoY
$142.2MFY 2025
FY21 $111.8MFY23 $135.7MFY24 $138.0MFY25 $142.2M

EPS (Diluted)

-3.5% YoY
$3.02FY 2025
FY21 $2.44FY23 $3.13FY24 $3.13FY25 $3.02

Total Assets

+7.0% YoY
$2.80BFY 2025
FY21 $2.84BFY23 $2.49BFY24 $2.61BFY25 $2.80B

Total Debt

+1.6% YoY
$1.16BFY 2025
FY21 $1.24BFY23 $1.14BFY24 $1.15BFY25 $1.16B

Op. Cash Flow

+13.9% YoY
$236.6MFY 2025
FY21 $210.9MFY23 $184.4MFY24 $207.8MFY25 $236.6M

AI Insight: NHI Financial Trends

Revenue surged 23% to $106M in Q4 2025 while debt-to-equity improved from 0.91x to 0.76x over the year.

Revenue grew from $86M in Q4 2024 to $106M in Q4 2025, marking 23% year-over-year growth.

Total debt decreased from $1,263M in Q1 2025 to $1,164M in Q4 2025 while equity strengthened.

Operating cash flow increased from $46M in Q1 2025 to $68M in Q4 2025.

Net income volatility continues with fluctuation between $29M-$43M across recent quarters despite revenue growth.

Revenue dipped to $90M in Q3 2025 from $91M in Q2 2025 before rebounding strongly in Q4.

AI Insight: NHI Ratio Trends

NHI's net profit margin declined from 50.4% in Q4 2024 to 36.1% in Q4 2025, while debt-to-equity improved from 0.91 to 0.76.

Net profit margin fell from 50.4% in Q4 2024 to 36.1% in Q4 2025, erasing prior gains.

Debt-to-equity ratio improved from 0.91 in Q1 2024 to 0.76 in Q4 2025, strengthening balance sheet.

ROE declined from 12.7% in Q4 2024 to 10.0% in Q4 2025 despite deleveraging efforts.

Net profit margin volatility remains high, swinging from 34.4% to 50.4% across recent quarters.

ROA has plateaued around 5% range since Q2 2024 despite balance sheet improvements.

Get alerted when NHI's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for NATIONAL HEALTH INVESTORS INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put NHI on your watchlist

Track score changes the day NATIONAL HEALTH INVESTORS INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is NHI a good stock to buy?

13F Pro's AI-powered analysis of NATIONAL HEALTH INVESTORS INC (NHI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Real Estate sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NHI are available on the NHI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own NHI?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NHI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NATIONAL HEALTH INVESTORS INC's investment landscape.